Drug and pharmaceutical recalls
17747 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIXylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVoriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVitamin B12 (3000 mcg/ml & 5000 mcg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVitamin A/D3/E Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIVitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IITripelennamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IITrimix, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IITestosterone Cypionate (100 mg/ml & 200 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IITaurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IITacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIStanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IISodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IISodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IISodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IISermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIQuadmix, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIProgesterone EO 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIProgesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPraziquantel 56.8mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPotassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPolidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPhenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPhenylbutazone 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPhentolamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPhenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief